Downregulation of CYP39A1 Serves as a Novel Biomarker in Hepatocellular Carcinoma with Worse Clinical Outcome

Figure 5

Correlation between CYP39A1 mRNA expression and clinicopathologic features of HCC in the TCGA database. (a) Tumor grade; (b) cancer stage; (c) patient age; (d) nodal metastasis; (e) gender; (f) histological type. (HCC: hepatocellular carcinoma; FCL: fibrolamellar carcinoma; mixed: hepatocholangio carcinoma).

(a)

(b)

(c)

(d)

(e)

(f)